WASHINGTON, DC—Administering tranexamic acid during noncardiac surgery provides a clear reduction in bleeding, with a low likelihood of harm in terms of vascular complications, the POISE-3 trial shows ...

Tranexamic acid (TXA) failed to reduce the need for red blood cell (RBC) transfusion following surgery for liver cancer, including colorectal liver metastases, the placebo-controlled HeLiX trial ...

A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The ...

An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a new study suggests. An hour can make the difference between life and ...

The clot stabilizer drug tranexamic acid can be administered safely to a wide range of patients with traumatic bleeding and should not be restricted to the most severe cases, a new study suggests. The ...

Please provide your email address to receive an email when new articles are posted on . Adrenaline and tranexamic acid each halted bleeding in 83.1% of patients. Moderate bleeding was stopped more ...

All patients with UGB should be evaluated for signs and symptoms of hemodynamic instability and active hemorrhage (i.e., hypotension, tachycardia, hematemesis, melena, and a precipitous drop in ...

Immediate treatment with tranexamic acid reduces the risk for death by 70% for people with severe bleeding, researchers say. However, rapid treatment initiation is important, as even short delays are ...

Percutaneous nephrolithotomy (PCNL) is a commonly used management strategy for upper urinary tract calculi; however, it is associated with adverse effects including fever, UTI, septicaemia and ...